SARS-CoV-2 productively infects human gut enterocytes

Abstract

Intestinal organoids as an infection model Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes an influenza-like disease with a respiratory transmission route; however, patients often present with gastrointestinal symptoms such as diarrhea, vomiting, and abdominal pain. Moreover, the virus has been detected in anal swabs, and cells in the inner-gut lining express the receptor that SARS-CoV-2 uses to gain entry to cells. Lamers et al. used human intestinal organoids, a “mini-gut” cultured in a dish, to demonstrate that SARS-CoV-2 readily replicates in an abundant cell type in the gut lining—the enterocyte—resulting in the production of large amounts of infective virus particles in the intestine. This work demonstrates that intestinal organoids can serve as a model to understand SARS-CoV-2 biology and infectivity in the gut. Science , this issue p. 50

References 44

1. 1.

   Drosten C., Günther S., Preiser W., van der Werf S., Brodt H.-R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R. A. M., Berger A., Burguière A.-M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.-C., Müller S., Rickerts V., Stürmer M., Vieth S., Klenk H.-D., Osterhaus A. D. M. E., Schmitz H., Doerr H. W., Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967–1976 (2003 ).

   Not in our library10.1056/nejmoa030747

2. 2.

   Guan W. J., Ni Z. Y., Hu Y., Liang W. H., Ou C. Q., He J. X., Liu L., Shan H., Lei C. L., Hui D. S. C., Du B., Li L. J., Zeng G., Yuen K.-Y., Chen R. C., Tang C. L., Wang T., Chen P. Y., Xiang J., Li S. Y., Wang J. L., Liang Z. J., Peng Y. X., Wei L., Liu Y., Hu Y. H., Peng P., Wang J. M., Liu J. Y., Chen Z., Li G., Zheng Z. J., Qiu S. Q., Luo J., Ye C. J., Zhu S. Y., Zhong N. S.; China Medical Treatment Expert Group for Covid-19, Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020 ).

   Not in our library10.1056/nejmoa2002032

3. 3.
   An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies · 2020

   Corrected
4. 4.

   Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G. F., Tan W.; China Novel Coronavirus Investigating and Research Team, A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020 ).

   Not in our library10.1056/nejmoa2001017

5. 5.

   Andersen K. G., Rambaut A., Lipkin W. I., Holmes E. C., Garry R. F., The proximal origin of SARS-CoV-2. Nat. Med. 26, 450–452 (2020 ).

   Not in our library10.1038/s41591-020-0820-9

6. 6.

   Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., Bi Y., Ma X., Zhan F., Wang L., Hu T., Zhou H., Hu Z., Zhou W., Zhao L., Chen J., Meng Y., Wang J., Lin Y., Yuan J., Xie Z., Ma J., Liu W. J., Wang D., Xu W., Holmes E. C., Gao G. F., Wu G., Chen W., Shi W., Tan W., Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 395, 565–574 (2020 ).

   Not in our library10.1016/s0140-6736(20)30251-8

7. 7.
   The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 · 2020

   No notice
8. 8.

   Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., Yang P., Sarao R., Wada T., Leong-Poi H., Crackower M. A., Fukamizu A., Hui C. C., Hein L., Uhlig S., Slutsky A. S., Jiang C., Penninger J. M., Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436, 112–116 (2005 ).

   Not in our library10.1038/nature03712

9. 9.

   Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., Bao L., Zhang B., Liu G., Wang Z., Chappell M., Liu Y., Zheng D., Leibbrandt A., Wada T., Slutsky A. S., Liu D., Qin C., Jiang C., Penninger J. M., A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11, 875–879 (2005 ).

   Not in our library10.1038/nm1267

10. 10.

    Walls A. C., Park Y. J., Tortorici M. A., Wall A., McGuire A. T., Veesler D., Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281–292.e6 (2020 ).

    Not in our library10.1016/j.cell.2020.02.058

11. 11.

    Wan Y., Shang J., Graham R., Baric R. S., Li F., Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 94, e00127-20 (2020 ).

    Not in our library10.1128/jvi.00127-20

12. 12.

    Wrapp D., Wang N., Corbett K. S., Goldsmith J. A., Hsieh C. L., Abiona O., Graham B. S., McLellan J. S., Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260–1263 (2020 ).

    Not in our library10.1126/science.abb2507

13. 13.

    Monteil V., Kwon H., Prado P., Hagelkrüys A., Wimmer R. A., Stahl M., Leopoldi A., Garreta E., Hurtado Del Pozo C., Prosper F., Romero J. P., Wirnsberger G., Zhang H., Slutsky A. S., Conder R., Montserrat N., Mirazimi A., Penninger J. M., Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell (2020 ).

    Not in our library10.1016/j.cell.2020.04.004

14. 14.

    Qi F., Qian S., Zhang S., Zhang Z., Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem. Biophys. Res. Commun. 526, 135–140 (2020 ).

    Not in our library10.1016/j.bbrc.2020.03.044

15. 15.

    Y. Zhao, Z. Zhao, Y. Wang, Y. Zhou, Y. Ma, W. Zuo, Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. bioRxiv 2020.01.26.919985 [Preprint]. 9 April 2010..

    Not in our library10.1101/2020.01.26.919985

16. 16.

    Jia H. P., Look D. C., Shi L., Hickey M., Pewe L., Netland J., Farzan M., Wohlford-Lenane C., Perlman S., McCray Jr. P. B., ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J. Virol. 79, 14614–14621 (2005 ).

    Not in our library10.1128/jvi.79.23.14614-14621.2005

17. 17.

    The Human Protein Atlas, ACE2 protein expression summary (2020); https://www.proteinatlas.org/ENSG00000130234-ACE2.

    Not in our library

18. 18.

    Gu J., Han B., Wang J., COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 158, 1518–1519 (2020 ).

    Not in our library10.1053/j.gastro.2020.02.054

19. 19.

    Cholankeril G., Podboy A., Aivaliotis V. I., Tarlow B., Pham E. A., Spencer S., Kim D., Hsing A., Ahmed A., High prevalence of concurrent gastrointestinal manifestations in patients with SARS-CoV-2: Early experience from California. Gastroenterology (2020 ).

    Not in our library10.1053/j.gastro.2020.04.008

20. 20.

    Wang W., Xu Y., Gao R., Lu R., Han K., Wu G., Tan W., Detection of SARS-CoV-2 in different types of clinical specimens. JAMA (2020 ).

    Not in our library10.1001/jama.2020.3786

21. 21.

    Holshue M. L., DeBolt C., Lindquist S., Lofy K. H., Wiesman J., Bruce H., Spitters C., Ericson K., Wilkerson S., Tural A., Diaz G., Cohn A., Fox L., Patel A., Gerber S. I., Kim L., Tong S., Lu X., Lindstrom S., Pallansch M. A., Weldon W. C., Biggs H. M., Uyeki T. M., Pillai S. K.; Washington State 2019-nCoV Case Investigation Team, First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 382, 929–936 (2020 ).

    Not in our library10.1056/nejmoa2001191

22. 22.

    Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H., Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology S0016-5085(20)30282-1 (2020 ).

    Not in our library10.1053/j.gastro.2020.02.055

23. 23.

    Sato T., Stange D. E., Ferrante M., Vries R. G. J., Van Es J. H., Van den Brink S., Van Houdt W. J., Pronk A., Van Gorp J., Siersema P. D., Clevers H., Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141, 1762–1772 (2011 ).

    Not in our library10.1053/j.gastro.2011.07.050

24. 24.

    Ettayebi K., Crawford S. E., Murakami K., Broughman J. R., Karandikar U., Tenge V. R., Neill F. H., Blutt S. E., Zeng X. L., Qu L., Kou B., Opekun A. R., Burrin D., Graham D. Y., Ramani S., Atmar R. L., Estes M. K., Replication of human noroviruses in stem cell-derived human enteroids. Science 353, 1387–1393 (2016 ).

    Not in our library10.1126/science.aaf5211

25. 25.

    Beumer J., Artegiani B., Post Y., Reimann F., Gribble F., Nguyen T. N., Zeng H., Van den Born M., Van Es J. H., Clevers H., Enteroendocrine cells switch hormone expression along the crypt-to-villus BMP signalling gradient. Nat. Cell Biol. 20, 909–916 (2018 ).

    Not in our library10.1038/s41556-018-0143-y

26. 26.

    Leung W. K., To K. F., Chan P. K. S., Chan H. L. Y., Wu A. K. L., Lee N., Yuen K. Y., Sung J. J. Y., Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 125, 1011–1017 (2003 ).

    Not in our library10.1016/j.gastro.2003.08.001

27. 27.

    Chan W. S., Wu C., Chow S. C. S., Cheung T., To K. F., Leung W. K., Chan P. K. S., Lee K. C., Ng H. K., Au D. M. Y., Lo A. W. I., Coronaviral hypothetical and structural proteins were found in the intestinal surface enterocytes and pneumocytes of severe acute respiratory syndrome (SARS). Mod. Pathol. 18, 1432–1439 (2005 ).

    Not in our library10.1038/modpathol.3800439

28. 28.

    Faas F. G. A., Avramut M. C., van den Berg B. M., Mommaas A. M., Koster A. J., Ravelli R. B. G., Virtual nanoscopy: Generation of ultra-large high resolution electron microscopy maps. J. Cell Biol. 198, 457–469 (2012 ).

    Not in our library10.1083/jcb.201201140

29. 29.
    SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum · 2008

    No notice
30. 30.

    McNutt N. S., Crain W. R., Quantitative electron microscopic comparison of lymphocyte nuclear contours in mycosis fungoides and in benign infiltrates in skin. Cancer 47, 698–709 (1981 ).

    Not in our library10.1002/1097-0142(19810215)47:4<698::aid-cncr2820470413>3.0.co;2-z

31. 31.

    Hosmillo M., Chaudhry Y., Nayak K., Sorgeloos F., Koo B. K., Merenda A., Lillestol R., Drumright L., Zilbauer M., Goodfellow I., Norovirus replication in human intestinal epithelial cells is restricted by the interferon-induced JAK/STAT signaling pathway and RNA polymerase II-mediated transcriptional responses. mBio 11, e00215-20 (2020 ).

    Not in our library10.1128/mbio.00215-20

32. 32.

    Saxena K., Simon L. M., Zeng X. L., Blutt S. E., Crawford S. E., Sastri N. P., Karandikar U. C., Ajami N. J., Zachos N. C., Kovbasnjuk O., Donowitz M., Conner M. E., Shaw C. A., Estes M. K., A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection. Proc. Natl. Acad. Sci. U.S.A. 114, E570–E579 (2017 ).

    Not in our library10.1073/pnas.1615422114

33. 33.

    Drummond C. G., Bolock A. M., Ma C., Luke C. J., Good M., Coyne C. B., Enteroviruses infect human enteroids and induce antiviral signaling in a cell lineage-specific manner. Proc. Natl. Acad. Sci. U.S.A. 114, 1672–1677 (2017 ).

    Not in our library10.1073/pnas.1617363114

34. 34.

    Good C., Wells A. I., Coyne C. B., Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci. Adv. 5, eaau4255 (2019 ).

    Not in our library10.1126/sciadv.aau4255

35. 35.

    Blanco-Melo D., Nilsson-Payant B. E., Liu W.-C., Uhl S., Hoagland D., Møller R., Jordan T. X., Oishi K., Panis M., Sachs D., Wang T. T., Schwartz R. E., Lim J. K., Albrecht R. A., Tenoever B. R., Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell (2020 ).

    Not in our library10.1016/j.cell.2020.04.026

36. 36.

    Sachs N., Papaspyropoulos A., Zomer-van Ommen D. D., Heo I., Böttinger L., Klay D., Weeber F., Huelsz-Prince G., Iakobachvili N., Amatngalim G. D., de Ligt J., van Hoeck A., Proost N., Viveen M. C., Lyubimova A., Teeven L., Derakhshan S., Korving J., Begthel H., Dekkers J. F., Kumawat K., Ramos E., van Oosterhout M. F., Offerhaus G. J., Wiener D. J., Olimpio E. P., Dijkstra K. K., Smit E. F., van der Linden M., Jaksani S., van de Ven M., Jonkers J., Rios A. C., Voest E. E., van Moorsel C. H., van der Ent C. K., Cuppen E., van Oudenaarden A., Coenjaerts F. E., Meyaard L., Bont L. J., Peters P. J., Tans S. J., van Zon J. S., Boj S. F., Vries R. G., Beekman J. M., Clevers H., Long-term expanding human airway organoids for disease modeling. EMBO J. 38, 100300 (2019 ).

    Not in our library10.15252/embj.2018100300

37. 37.
    Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR · 2020

    Expression of concern
38. 38.

    Muñoz J., Stange D. E., Schepers A. G., van de Wetering M., Koo B.-K., Itzkovitz S., Volckmann R., Kung K. S., Koster J., Radulescu S., Myant K., Versteeg R., Sansom O. J., van Es J. H., Barker N., van Oudenaarden A., Mohammed S., Heck A. J. R., Clevers H., The Lgr5 intestinal stem cell signature: Robust expression of proposed quiescent ‘+4’ cell markers. EMBO J. 31, 3079–3091 (2012 ).

    Not in our library10.1038/emboj.2012.166

39. 39.
    CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq · 2016

    No notice
40. 40.

    Simmini S., Bialecka M., Huch M., Kester L., van de Wetering M., Sato T., Beck F., van Oudenaarden A., Clevers H., Deschamps J., Transformation of intestinal stem cells into gastric stem cells on loss of transcription factor Cdx2. Nat. Commun. 5, 5728 (2014 ).

    Not in our library10.1038/ncomms6728

Cited by papers we hold 68

• Mucosal immune response in biology, disease prevention and treatment · 2025
  No notice
• Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) · 2023
  No notice
• Role of gut microbiota in infectious and inflammatory diseases · 2023
  No notice
• Increased TRIM31 gene expression is positively correlated with SARS-CoV-2 associated genes TMPRSS2 and TMPRSS4 in gastrointestinal cancers · 2022
  Not checked
• CRISPR-Cas9-Based Technology for Studying Enteric Virus Infection · 2022
  Not checked
• Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia · 2022
  No notice
• Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct · 2022
  No notice
• A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic · 2022
  No notice
• Long COVID and its Management · 2022
  No notice
• Human organoids in basic research and clinical applications · 2022
  No notice
• FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2 · 2022
  No notice
• Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients · 2022
  No notice
• SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery · 2022
  No notice
• Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy · 2021
  No notice
• The total number and mass of SARS-CoV-2 virions · 2021
  No notice
• The Mechanisms and Animal Models of SARS-CoV-2 Infection · 2021
  Not checked
• Distinct Metagenomic Signatures in the SARS-CoV-2 Infection · 2021
  Not checked
• Stability and Infectivity of SARS-CoV-2 and Viral RNA in Water, Commercial Beverages, and Bodily Fluids · 2021
  Not checked
• COVID-19 Mechanisms in the Human Body—What We Know So Far · 2021
  Not checked
• OME-NGFF: a next-generation file format for expanding bioimaging data-access strategies · 2021
  No notice

and 48 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.